Han Myung Lee - 09 Dec 2025 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role: Director
Signature: /s/ Douglas Carr, Attorney-in-Fact
Issuer symbol: IPSC
Transactions as of: 09 Dec 2025
Net transactions value: $0
Form type: 4
Filing time: 11 Dec 2025, 18:04:57 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lee Han Myung	Director	25 N 38TH ST., 11TH FLOOR, PHILADELPHIA	/s/ Douglas Carr, Attorney-in-Fact	11 Dec 2025	0002100154

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IPSC	Stock Option (right to buy)	Award	$0	+88,000		$0.000000	88,000	09 Dec 2025	Common Stock	88,000	$0.5920	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Century Therapeutics, Inc. (the "Company") issued to the Reporting Person stock options (the "Options") in connection with his appointment as a director. The Options vest in equal monthly installments over 36 months subject to the Reporting Person's continued service to the Company and are issued pursuant to the Company's 2021 Equity Incentive Plan.